Steve Davis, who has been described as Elon Musk's fixer, has helped oversee the mass firings of government workers in DC. A ...

Steve Davis, a longtime Musk loyalist, is effectively the leader of the Department of Government Efficiency. Mr. Musk has ...

"Without researchers there is no research, and without education there are no researchers," writes one reader.

Meet the cost-cutting engineer who runs the day-to-day operations of DOGE and is a ‘blind servant’ to Musk - Elon Musk once ...

Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...

MacroGenics (NASDAQ: MGNX) Q4 2024 Earnings Call Mar 20, 2025, 4:30 p.m. ET ...

Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced ...

Is the U.S. economy headed for a recession? Stocks have plunged. So have measures of consumer and business confidence. Forecasters expect slower growth, higher unemployment and faster inflation than ...

Elevation Oncology discontinues EO-3021 for gastric and gastroesophageal junction cancers after phase 1 trial shows ...

Remains on Track to Initiate an Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma in 2025 ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It's the latest example ...